1. Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
   Maryamsadat Shahidi et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
2. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
   Shaymaa M. M. Yahya et al, 2024, Breast Cancer Research and Treatment CrossRef
3. ASSOCIATION OF MICRORNA EXPRESSION WITH EARLY STAGE OF BREAST CANCER METASTASIS
   Kristina A. Grishina et al, 2018, Russian Journal of Oncology CrossRef
4. Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial–Mesenchymal Transition in Thyroid Carcinoma Cells
   Chang Liu et al, 2020, Frontiers in Oncology CrossRef
5. MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer
   Felipe Silva de Miranda et al, 2024, Frontiers in Molecular Biosciences CrossRef
6. MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis
   Adriana Fodor et al, 2021, International Journal of Molecular Sciences CrossRef
7. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
   Aimi Syamima Abdul Manap et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
8. Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
   Tomasz M. Grzywa et al, 2020, Cancers CrossRef
9. Notch Signalling in Breast Development and Cancer
   Abigail Edwards et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
10. Recent advances in novel miRNA mediated approaches for targeting breast cancer
    Seyedeh Melika Ahmadi et al, 2023, Journal of Drug Targeting CrossRef
11. Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients
    Klara Cervena et al, 2021, Frontiers in Oncology CrossRef
12. Mesenchymal stem cells and cancer‐associated fibroblasts as a therapeutic strategy for breast cancer
    Francisco Raúl Borzone et al, 2024, British Journal of Pharmacology CrossRef